Is the drug Hydrocodone a sulfa based or derived drug?

Answer 1

"Sulfa" medications are a class of antibiotic. This group includes mostly antiquated compounds that are not used anymore. An exception is sulfamethoxazole which is sold as "Bactrim", a mixture of sulfamethoxazole and trimethoprim.

By the question, my guess is that you are (or someone else is) sulfa allergic and you are concerned about taking this medication. This is not a worry if sulfa is the only allergy involved. Hydrocodone is a narcotic pain medication with absolutely no relationship to sulfa antibiotics. This being said, however, there are side effects to pain medications and people can have allergies to these as well.

If you believe that you are having an adverse reaction to a medication, contact the prescribing physician immediately.

I hope you feel better soon :)

Answer 2

Sulfa Based Drugs

Answer 3

Sulfa Meds

Answer 4

No.....hydrocodone is an opiate based painkiller. Sufa based drugs are antibiotics. I am allergic to sulfa but have no problems with hydrocodone.

Answer 5

No, Hydrocodone is synthetic codeine and is in fact related to the opiates. Sulfa refers to drugs of a different category ie antibiotics.

Answer 6

1

Answer 7

It is not

Answer 8

no, it's a opiate.

Answer 9

no. But to make sure talk to your doctor; (a-mox-i-sill'in) amoxicillin, Amoxil, Apo-Amoxi , DisperMox, Novamoxin , Nu-Amoxi , Trimox, Wymox Func. class.: Antiinfective, antiulcer Chem. class.: Aminopenicillin Do not confuse: amoxicillin/amoxapine/Amoxil Trimox/Diamox/Tylox Wymox/Tylox Action: Interferes with cell wall replication of susceptible organisms; the cell wall, rendered osmotically unstable, swells and bursts from osmotic pressure; bactericidal, lysis mediated by bacterial cell wall autolysins Uses: Treatment of skin, respiratory, GI, GU infections; otitis media, gonorrhea. For gram-positive cocci (Staphylococcus aureus, Streptococcus pyogenes, Streptococcus faecalis, Streptococcus pneumoniae), gram-negative cocci (Neisseria gonorrhoeae, Neisseria meningitidis), gram-positive bacilli (Corynebacterium diphtheriae, Listeria monocytogenes), gram-negative bacilli (Haemophilus influenzae, Escherichia coli, Proteus mirabilis, Salmonella); prophylaxis of bacterial endocarditis; in combination with other drugs used for treatment of Helicobacter pylori Unlabeled uses: Lyme disease, anthrax treatment, and prophylaxis DOSAGE AND ROUTES Systemic infections • Adult: PO 750 mg-1.75 g daily in divided doses q8h • Child: PO 20-50 mg/kg/day in divided doses q8h Renal disease • Adult: PO CCr 10-30 ml/min 250-500 mg q12h; CCr <10 ml/min 250-500 mg q24h; do not use 875 mg strength if CCr <50 ml/min Gonorrhea/urinary tract infections • Adult: PO 3 g given with 1 g probenecid as a single dose; followed by tetracycline or erythromycin therapy Chlamydia trachomatis • Adult: PO 500 mg/tid × 1 wk Bacterial endocarditis prophylaxis • Adult: PO 2 g 1 hr prior to procedure • Child: PO 50 mg/kg/hr 1 hr prior to procedure; max 2 g Helicobacter pylori • Adult: PO 1000 mg bid, given with lansoprazole 30 mg bid, clarithromycin 500 mg bid × 2 wk or 1000 mg bid given with omeprazole 20 mg bid, clarithromycin 500 mg bid × 2 wk, or 1000 mg tid given with lansoprazole 30 mg tid × 2 wk Available forms: Caps 250, 500 mg; chew tabs 125, 200, 250, 400 mg; tabs 500, 875 mg; susp pediatric drops 50 mg/ml; susp 125, 200, 250, 400 mg/5 ml SIDE EFFECTS CNS: Headache, seizures GI: Nausea, vomiting, diarrhea, increased AST, ALT, abdominal pain, glossitis, colitis, pseudomembranous colitis HEMA: Anemia, increased bleeding time, bone marrow depression, granulocytopenia INTEG: Urticaria, rash SYST: Anaphylaxis, respiratory distress, serum sickness, Stevens-Johnson syndrome Contraindications: Hypersensitivity to penicillins Precautions: Pregnancy (B), lactation, hypersensitivity to cephalosporins, neonates, severe renal disease, acute lymphocytic leukemia PHARMACOKINETICS PO: Peak 2 hr, duration 6-8 hr; half-life 1-1⅓ hr, metabolized in liver, excreted in urine, crosses placenta, enters breast milk INTERACTIONS Increase: amoxicillin level—probenecid Increase: anticoagulant action—warfarin Increase: methotrexate levels—methotrexate Decrease: effectiveness of oral contraceptives Drug/Herb • Do not use acidophilus with antiinfectives; separate by several hours Decrease: absorption—khat; separate by 2 hr Drug/Lab Test False positive: Urine glucose, urine protein, direct Coombs' test NURSING CONSIDERATIONS Assess: • I&O ratio; report hematuria, oliguria, since penicillin in high doses is nephrotoxic • Any patient with a compromised renal system, since drug is excreted slowly in poor renal system function; toxicity may occur rapidly • Hepatic studies: AST, ALT • Blood studies: WBC, RBC, Hgb and Hct, bleeding time • Renal studies: urinalysis, protein, blood, BUN, creatinine • C&S before drug therapy; drug may be given as soon as culture is taken • Bowel pattern before, during treatment; diarrhea, cramping, blood in stools, report to prescriber; pseudomembranous colitis may occur • Skin eruptions after administration of penicillin to 1 wk after discontinuing drug • Respiratory status: rate, character, wheezing, tightness in the chest • Anaphylaxis: rash, itching, dyspnea, facial/laryngeal edema Administer: PO route • Shake suspension well before each dose; may be used alone or mixed in drinks; use immediately; discard unused portion of susp after 14 days • Give around the clock, caps may be emptied and mixed with liquids if needed Perform/provide: • Adrenaline, suction, tracheostomy set, endotracheal intubation equipment on unit • Adequate intake of fluids (2 L) during diarrhea episodes • Scratch test to assess allergy after securing order from prescriber; usually done when penicillin is only drug of choice • Storage in tight container; after reconstituting, oral suspension refrigerated for 14 days Evaluate: • Therapeutic response: absence of infection; prevention of endocarditis, resolution of ulcer symptoms Teach patient/family: • That caps ma